Skip to main content

Advertisement

Table 2 Insulin premixture formulations

From: Evidence-based clinical use of insulin premixtures

Manufacturer Commercial name Composition
Eli Lilly and Company Humulin® 70/30 70% human insulin isophane suspension, 30% regular human insulin
Humalog® Mix25™ 25% insulin lispro, 75% insulin lispro protamine suspension
Humalog® Mix50™ 50% insulin lispro, 50% insulin lispro protamine suspension
Novo Nordisk Novolin® 70/30* 70% human insulin isophane suspension, 30% regular human insulin
NovoMix® 30 70% protamine-crystallized insulin aspart and 30% insulin aspart
  NovoMix® 50* 50% protamine-crystallized insulin aspart and 50% insulin aspart
  1. * Not available commercially in Brazil but still available in many other countries; approved by the U.S. Food and Drug Administration and the European Medicines Evaluation Agency.